Organon & Co. Declares Quarterly Dividend

Dividend of $0.02 per share to be paid on March 12th

Published on Feb. 21, 2026

Got story updates? Submit your updates here. ›

Organon & Co. (NYSE:OGN), a global healthcare company focused on women's health, biosimilars, and established brands, announced that it will pay a quarterly dividend of $0.02 per share on March 12th to shareholders of record as of February 23rd.

Why it matters

The dividend payout indicates Organon's financial stability and commitment to returning value to shareholders. As a newly independent company, this dividend helps establish Organon as an attractive investment option in the pharmaceutical sector.

The details

The $0.02 quarterly dividend represents an annualized yield of 1.0% based on Organon's current stock price. The company's payout ratio of 2.0% suggests the dividend is well covered by earnings, which are expected to be $3.74 per share next year.

  • Organon declared the dividend on Thursday, February 12th.
  • The dividend will be paid on Thursday, March 12th.
  • The ex-dividend date is Monday, February 23rd.

The players

Organon & Co.

A global healthcare company that was established as an independent, publicly traded entity following its spin-off from Merck & Co in June 2021. Organon focuses on delivering therapeutic solutions across women's health, biosimilars, and established brands.

Got photos? Submit your photos here. ›

What’s next

Organon's shareholders will receive the $0.02 per share dividend on March 12th.

The takeaway

Organon's first quarterly dividend payment demonstrates the company's financial strength and commitment to rewarding shareholders as it establishes itself as an independent pharmaceutical player focused on women's health and other key therapeutic areas.